Israel Active

A team of doctors at Petah Tikva's Beilinson Hospital have succeeded in surgically removing a 15cm long tumor from a woman's womb in the middle of her pregnancy without harming her or the baby. Danielle Skald later had a normal delivery of a baby boy.

Israel is donating two skin graft meshers worth more than $10,000 each, to Taiwanese hospitals. 498 people were injured (202 in need of skin grafts) following a horrific water park explosion accident in a Taipei water park.

Israeli medical clowns from “Dream Doctors” visited seven hospitals and orphanages in Chengdu, southwestern China. In colorful clown costumes and with big red noses, they sang songs, played ukulele, performed magic tricks and blew bubbles in the wards to cheer up the patients.  

Israel’s MeMed has discovered a protein in blood called TRAIL that dramatically increases in patients infected with viruses but decreases in bacterial infections. It has developed proprietary algorithms and a blood test called ImmunoXpert that could save hundreds of thousands of lives in Europe alone.

I reported previously on the successful results of the acne treatment from Israel’s Foamix. The company’s Rosacea treatment - Finacea Foam - has just been approved by the US FDA. Rosacea is a skin condition of unattractive dilated blood vessels, often on the face.  

The Hebrew University of Jerusalem and the Hadassah Medical Center will establish the first interdisciplinary university-based autism center in the Middle East. The Autism Center will bring together cutting-edge research, clinical services, state of the art training and education for professionals and parents in the community.

Another liver cell innovation from scientists at the Hebrew University of Jerusalem who have partnered with Germany’s Fraunhofer Institute to build a a liver-on-chip device mimicking human physiology. Soon, toxicity tests no longer need performing on animals.

Israel’s Nervomatrix has reported success from independent controlled trials of its hyper-stimulation pulse device for treating lower back pain. The study on 28 patients at Belgian’s Free University of Brussels obtained significant pain relief after 4 treatments compared to a control group.

The US FDA has given fast track approval to Israel’s BioBlast for its Cabaletta treatment for two rare and currently untreatable conditions - oculopharyngeal muscular dystrophy (OPMD) and spinocerebellar ataxia type 3 (SCA3).

Israel’s BiondVax has published independent tests of trials showing that its M-001 Universal Flu vaccinations given 3 years ago have protected patients from flu strains that only came into existence well after the vaccine was administered.